These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 32695197)
1. Analysis of clinical utilization of ring applicator for combined intracavitary/interstitial image-guided brachytherapy treatment in Chinese patients with locally advanced cervical cancer. Zhao Z; Zhang N; Liu Y; Wu N; Mao Z; Yang W; Cheng G J Contemp Brachytherapy; 2020 Jun; 12(3):252-259. PubMed ID: 32695197 [TBL] [Abstract][Full Text] [Related]
2. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer. Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732 [TBL] [Abstract][Full Text] [Related]
3. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer. Assenholt MS; Petersen JB; Nielsen SK; Lindegaard JC; Tanderup K Acta Oncol; 2008; 47(7):1337-43. PubMed ID: 18663651 [TBL] [Abstract][Full Text] [Related]
4. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component. Fokdal L; Tanderup K; Hokland SB; Røhl L; Pedersen EM; Nielsen SK; Paludan M; Lindegaard JC Radiother Oncol; 2013 Apr; 107(1):63-8. PubMed ID: 23452917 [TBL] [Abstract][Full Text] [Related]
5. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer. Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505 [TBL] [Abstract][Full Text] [Related]
6. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results. Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345 [TBL] [Abstract][Full Text] [Related]
7. A novel minimally invasive dynamic-shield, intensity-modulated brachytherapy system for the treatment of cervical cancer. Morcos M; Antaki M; Viswanathan AN; Enger SA Med Phys; 2021 Jan; 48(1):71-79. PubMed ID: 32916763 [TBL] [Abstract][Full Text] [Related]
8. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy. Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131 [TBL] [Abstract][Full Text] [Related]
9. Intracavitary/Interstitial Applicator Plus Distal Parametrial Free Needle Interstitial Brachytherapy in Locally Advanced Cervical Cancer: A Dosimetric Study. Qu HD; Han DM; Zhang N; Mao Z; Cheng GH Front Oncol; 2020; 10():621347. PubMed ID: 33680943 [TBL] [Abstract][Full Text] [Related]
10. Outcomes and comparison of dosimetric parameters between intracavitary (Fletcher) and combined intracavitary/interstitial (Utrecht) brachytherapy in locally advanced cervical cancer. Sarwar KA; Hussain S; Syed AS; Khan K; Maqsood T; Azeem T Brachytherapy; 2024; 23(1):10-17. PubMed ID: 37813708 [TBL] [Abstract][Full Text] [Related]
11. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer. Jürgenliemk-Schulz IM; Tersteeg RJ; Roesink JM; Bijmolt S; Nomden CN; Moerland MA; de Leeuw AA Radiother Oncol; 2009 Nov; 93(2):322-30. PubMed ID: 19748695 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the Dosimetric Influence of Applicator Displacement on 2D and 3D Brachytherapy for Cervical Cancer Treatment. Wu A; Tang D; Wu A; Liu Y; Qian L; Zhu L Technol Cancer Res Treat; 2021; 20():15330338211041201. PubMed ID: 34569371 [TBL] [Abstract][Full Text] [Related]
13. Feasibility of applying a single treatment plan for both fractions in PDR image guided brachytherapy in cervix cancer. Mohamed S; Nielsen SK; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K Radiother Oncol; 2013 Apr; 107(1):32-8. PubMed ID: 23333020 [TBL] [Abstract][Full Text] [Related]
14. Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction. Nesvacil N; Pötter R; Sturdza A; Hegazy N; Federico M; Kirisits C Radiother Oncol; 2013 Apr; 107(1):75-81. PubMed ID: 23068712 [TBL] [Abstract][Full Text] [Related]
15. Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer. Liu ZS; Guo J; Lin X; Wang HY; Qiu L; Ren XJ; Li YF; Zhang BY; Wang TJ Brachytherapy; 2016; 15(5):562-9. PubMed ID: 27474180 [TBL] [Abstract][Full Text] [Related]
16. Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the Hopfensperger KM; Adams Q; Kim Y; Wu X; Xu W; Patwardhan K; Thammavong B; Caster J; Flynn RT Med Phys; 2020 Jun; 47(5):2061-2071. PubMed ID: 32073669 [TBL] [Abstract][Full Text] [Related]
17. Interstitial round needles should not be used for cervical cancer patient treated with intracavitary/ interstitial brachytherapy using a Venezia applicator : a case report. Takagawa Y; Izumi S; Takahashi E; Kita M BMC Womens Health; 2024 Apr; 24(1):249. PubMed ID: 38637783 [TBL] [Abstract][Full Text] [Related]
18. Parametrial boosting in locally advanced cervical cancer: combined intracavitary/interstitial brachytherapy vs. intracavitary brachytherapy plus external beam radiotherapy. Mohamed S; Kallehauge J; Fokdal L; Lindegaard JC; Tanderup K Brachytherapy; 2015; 14(1):23-8. PubMed ID: 25455382 [TBL] [Abstract][Full Text] [Related]
19. Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT. Benkhaled S; Diakité K; Jullian N; Poeta S; Vandekerkhove C; Van Houtte P; Van Gestel D; De Caluwé A Radiat Oncol; 2023 Jun; 18(1):105. PubMed ID: 37381016 [TBL] [Abstract][Full Text] [Related]
20. Predicting which patients may benefit from the hybrid intracavitary+interstitial needle (IC/IS) applicator for advanced cervical cancer: A dosimetric comparison and toxicity benefit analysis. Gonzalez Y; Giap F; Klages P; Owrangi A; Jia X; Albuquerque K Brachytherapy; 2021; 20(1):136-145. PubMed ID: 33132073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]